Hemo Organic Board of Directors
Get the latest insights into the leadership at Hemo Organic. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Vishwambar Kameshwar Singh | Managing Director |
| Mrs. Siyonaa Jhanwar | Non Executive Director |
| Mr. Murlidhar Joshi | Non Executive Director |
| Ms. Hiral Vinodbhai Patel | Independent Director |
| Ms. Rina Kumari | Independent Director |
Hemo Organic Share price
HEMORGANIC
10.75
0.04 (-0.37%)Last updated on 4 Sep, 2025 | 12:15 IST
BUYSELL
Today's High
10.79
Today's Low
10.75
52 Week Low
8.05
52 Week High
15.25
The current prices are delayed, login to your account for live prices
LoginHemo Organic FAQs
The board at Hemo Organic consists of experienced professionals, including Mr. Vishwambar Kameshwar Singh , Mrs. Siyonaa Jhanwar , and others, overseeing the company’s strategic and corporate governance.
Directors at Hemo Organic are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Vishwambar Kameshwar Singh is the current chairman at Hemo Organic.
Executive directors at Hemo Organic are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Hemo Organic adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Hemo Organic, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.